Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, posted on X:
“My Fred Hutchinson Cancer Center colleague Jake Appelbaum rounding out amazing session with ongoing study of decoy-resistant IL-18 after allo HCT in MDS and AML.
Who needs custom IL-18 armoring if you can give off-the-shelf IL-18 that sticks around?
We will see – exciting science!”
